drugset / Trial / NCT01777581

Milnacipran for Lumbosacral Radicular Pain

NCT01777581

Phase 4 Completed 13 enrolled Duke University Forest Laboratories · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study investigates whether milnacipran reduces radicular pain ("sciatica") in patients with lumbosacral disc disease.

Timeline

Start
2010-03
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified 100 mg
Subject Milnacipran Other / unclassified 200 mg

Indications